SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-247714
Filing Date
2021-08-16
Accepted
2021-08-16 16:09:08
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d202147d10q.htm   iXBRL 10-Q 1796783
2 EX-31.1 d202147dex311.htm EX-31.1 9951
3 EX-31.2 d202147dex312.htm EX-31.2 9926
4 EX-32.1 d202147dex321.htm EX-32.1 4450
5 EX-32.2 d202147dex322.htm EX-32.2 4360
  Complete submission text file 0001193125-21-247714.txt   6197455

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vera-20210630.xsd EX-101.SCH 54169
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vera-20210630_cal.xml EX-101.CAL 35342
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vera-20210630_def.xml EX-101.DEF 258343
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20210630_lab.xml EX-101.LAB 386804
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20210630_pre.xml EX-101.PRE 328252
11 EXTRACTED XBRL INSTANCE DOCUMENT d202147d10q_htm.xml XML 776728
Mailing Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 211178163
SIC: 2834 Pharmaceutical Preparations